Fundraising FoxFACIT (Fight Against Cancer Innovation Trust) — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Esphera SynBio Inc.espherasynbio.cainSeed · Jan 2025 · $2M
Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.
BiotechDeep TechMedical DevicesToronto, CA
Brian Lichty(Founder, CEO)inCarolina Ilkow(Founder, CSO)inJohn Bell(Founder, President)in
Co-investorsOntario Centre of InnovationOntario Centre of Innovation programs
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.